ENTRY       C07666                      Compound
NAME        Dapsone;
            4,4'-Sulfonylbisbenzenamine;
            Diaphenylsulfone
FORMULA     C12H12N2O2S
EXACT_MASS  248.0619
MOL_WEIGHT  248.3009
REMARK      Same as: D00592
BRITE       Carcinogens [BR:br08008]
             Group 3: Not classifiable as to its carcinogenicity to humans
              Compounds
               C07666  Dapsone
            Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AX Other anti-acne preparations for topical use
                 D10AX05 Dapsone
                  D00592  Diaphenylsulfone (JAN); Dapsone (USP)
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J04 ANTIMYCOBACTERIALS
               J04B DRUGS FOR TREATMENT OF LEPRA
                J04BA Drugs for treatment of lepra
                 J04BA02 Dapsone
                  D00592  Diaphenylsulfone (JAN); Dapsone (USP)
            USP drug classification [BR:br08302]
             Antimycobacterials
              Antimycobacterials, Other
               Dapsone
                D00592  Diaphenylsulfone (JAN); Dapsone (USP)
             Dermatological Agents
              Dapsone
               D00592  Diaphenylsulfone (JAN); Dapsone (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               269  Miscellaneous
                2699  Others
                 D00592  Diaphenylsulfone (JAN); Dapsone (USP)
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               623  Leprostatics
                6231  Sulfones
                 D00592  Diaphenylsulfone (JAN); Dapsone (USP)
            Antiinfectives [BR:br08307]
             Antibacterials
              Folic acid biosynthesis inhibitor
               dihydropteroate synthase inhibitor
                Others
                 Dapsone; Antileprosy drug
                  D00592  Diaphenylsulfone (JAN); Dapsone (USP)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP3A4
               Diaphenylsulfone
                D00592  Diaphenylsulfone (JAN); Dapsone (USP)
DBLINKS     CAS: 80-08-0
            PubChem: 9868
            ChEBI: 4325
            NIKKAJI: J4.247A
ATOM        17
            1   S4a S    21.9800  -14.6136
            2   C8y C    23.1922  -15.3246
            3   C8y C    20.7736  -15.3187
            4   O3c O    20.9776  -13.6228
            5   O3c O    22.9708  -13.6228
            6   C8x C    24.4045  -14.6195
            7   C8x C    23.1922  -16.7234
            8   C8x C    19.5614  -14.6136
            9   C8x C    20.7736  -16.7175
            10  C8x C    25.6050  -15.3187
            11  C8x C    24.4045  -17.4168
            12  C8x C    18.3433  -15.3187
            13  C8x C    19.5614  -17.4168
            14  C8y C    25.6167  -16.7234
            15  C8y C    18.3433  -16.7175
            16  N1a N    26.8174  -17.4285
            17  N1a N    17.1369  -17.4168
BOND        18
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     1   5 2
            5     2   6 2
            6     2   7 1
            7     3   8 2
            8     3   9 1
            9     6  10 1
            10    7  11 2
            11    8  12 1
            12    9  13 2
            13   10  14 2
            14   12  15 2
            15   14  16 1
            16   15  17 1
            17   11  14 1
            18   13  15 1
///
